Merck & Company (MRK)

Mar 27, 2025, 11:03 AM EDT - 4 days ago

Merck plans US to launch subcutaneous version of Keytruda on October 1

Mar 27, 2025, 11:01 AM EDT - 4 days ago

Merck's Investigational Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous (IV) KEYTRUDA® (pembrolizumab) in Pivotal 3475A-D77 Trial

Mar 27, 2025, 10:22 AM EDT - 4 days ago

Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector.

ABBV AMGN BIIB BMY GILD IHE JNJ

Mar 27, 2025, 7:40 AM EDT - 4 days ago

Biotech stocks have been hit hard. Why they're a great value now.

PFE BHVN DNLI GPCR INSM SWTX

Mar 26, 2025, 11:00 AM EDT - 5 days ago

Forget S&P 500 And Buy These Dividend Icons Instead

ES

Mar 26, 2025, 6:45 AM EDT - 5 days ago

European Commission (EC) Approves Merck's CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

Mar 25, 2025, 6:59 AM EDT - 6 days ago

Merck signs deal with Jiangsu Hengrui worth up to $2 billion for access to heart drug

Mar 25, 2025, 6:45 AM EDT - 6 days ago

Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Mar 21, 2025, 7:21 AM EDT - 10 days ago

Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy

BMY

Mar 19, 2025, 6:45 AM EDT - 12 days ago

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease

Mar 15, 2025, 8:37 AM EDT - 16 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

Mar 14, 2025, 6:08 PM EDT - 17 days ago

Drugmakers agree to participate in second round of price negotiations

ABBV AZN GSK NVO TEVA

Mar 12, 2025, 11:26 AM EDT - 19 days ago

Merck Announces Positive Data from Phase 3 Trials that Show the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) Maintained HIV-1 Viral Suppression at Week 48

Mar 11, 2025, 4:38 PM EDT - 20 days ago

Merck prevails in Gardasil safety litigation

Mar 11, 2025, 6:57 AM EDT - 20 days ago

Merck opens vaccine manufacturing facility in North Carolina

Mar 11, 2025, 6:45 AM EDT - 20 days ago

Merck Unveils New Facility to Increase Vaccine Production Capacity

Mar 8, 2025, 7:52 AM EST - 23 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

Mar 5, 2025, 5:51 AM EST - 26 days ago

New version of Merck's cancer drug faces patent battle, WSJ reports

Mar 4, 2025, 2:56 PM EST - 27 days ago

Dogs Of The Dow Chase A "Safer" Buy For March

AMGN AMZN BA CAT CRM CSCO CVX

Mar 4, 2025, 9:21 AM EST - 27 days ago

Trends Shaping the Global Livestock Monitoring Market 2025-2031, Featuring Case Study Analysis and Profiles of Industry Giants - Merck & Co., GEA Group, DeLaval, Nedap, Afimilk & More

Mar 3, 2025, 7:13 PM EST - 27 days ago

Merck & Co., Inc. (MRK) Presents at TD Cowen 45th Annual Health Care Conference (Transcript)

Mar 3, 2025, 1:20 PM EST - 4 weeks ago

Investors in Merck & Co., Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – MRK

Mar 3, 2025, 8:00 AM EST - 4 weeks ago

Buy These Mispriced Dividend Icons For Retirement Income

O

Mar 3, 2025, 5:45 AM EST - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK

Mar 3, 2025, 1:04 AM EST - 4 weeks ago

My Top 10 High-Yield Dividend Stocks For March 2025

AMT CM CMCSA NEE PNC QSR RY

Mar 1, 2025, 8:00 AM EST - 4 weeks ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Upto 8% (March 2025)

ACN ADM ADP ARCC AVGO BTI CI

Feb 27, 2025, 12:00 PM EST - 4 weeks ago

Deadline Approaching: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Feb 26, 2025, 9:15 AM EST - 4 weeks ago

Merck's Oncology Strength: Beating Wall Street Again

Feb 26, 2025, 9:04 AM EST - 4 weeks ago

US drugmaker Merck to boost workforce in India, executive says

Feb 25, 2025, 4:59 PM EST - 4 weeks ago

Merck expects cancer therapy Keytruda to be part of government price setting in 2026

Feb 25, 2025, 9:00 AM EST - 4 weeks ago

10 Undervalued Dividend Growth Stocks: February 2025

AMGN EOG HSY MAA MDLZ NEE PEP

Feb 25, 2025, 6:45 AM EST - 4 weeks ago

FDA Grants Priority Review to Merck's Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma